stool
sampl
contain
high
concentr
cyclospora
oocyst
serum
specimen
collect
person
cyclosporiasi
haiti
unit
state
inform
consent
obtain
person
provid
specimen
center
diseas
control
prevent
cdc
institut
review
board
irb
review
specimen
collect
inform
consent
patient
counsel
procedur
stool
specimen
homogen
water
siev
cheesecloth
sinc
cyclospora
oocyst
must
form
sporocyst
outsid
human
host
becom
infecti
filtrat
resuspend
potassium
dichrom
shaken
week
room
temperatur
induc
sporul
sporul
oocyst
sporul
sampl
store
room
temperatur
process
month
suspens
highest
oocyst
count
purifi
concentr
sucros
cesium
chlorid
gradient
see
tabl
addit
inoculum
treatment
condit
candid
inoculum
test
salmonella
spp
shigella
spp
campylobact
spp
yersinia
spp
mycobacterium
spp
escherichia
coli
enterovirus
hepat
viru
hav
herpesviru
cytomegaloviru
coronaviru
astroviru
rotaviru
noroviru
adenoviru
hiv
clostridium
difficil
toxin
enterotoxin
intestin
parasit
data
shown
serum
specimen
donor
cyclosporaposit
stool
test
serum
marker
hiv
hav
hepat
b
viru
taenia
solium
serum
cyclosporaposit
stool
donor
test
posit
oocyst
person
use
candid
inocula
none
pathogen
toxin
found
use
human
challeng
studi
safetytest
protocol
review
approv
univers
north
carolina
school
medicin
irb
cdc
irb
cell
cultur
infect
assay
anim
model
avail
determin
infect
viabil
oocyst
attempt
made
assess
viabil
inoculum
observ
sporozoit
motil
excyst
oocyst
differ
method
howev
method
yield
suffici
number
motil
sporozoit
measur
viabil
studi
conduct
gener
clin
ical
research
center
univers
north
carolina
hospit
chapel
hill
nc
inclus
exclus
criteria
determin
whether
person
elig
particip
studi
healthi
volunt
recruit
univers
north
carolina
unc
chapel
hill
nc
surround
commun
enrol
candid
receiv
medic
evalu
preinocul
serum
specimen
collect
archiv
seven
studi
particip
compris
four
women
three
men
three
white
four
african
american
median
age
ingest
inoculum
volunt
ask
collect
stool
specimen
week
one
specimen
week
week
also
ask
keep
daili
record
physic
symptom
time
stool
passag
addit
volunt
provid
blood
saliva
specimen
weekli
week
week
postdos
studi
outcom
measur
shed
cyclospora
oocyst
stool
b
frequenc
weight
color
consist
stool
c
clinic
symptom
gastroenter
diarrhea
stool
hour
nausea
vomit
abdomin
pain
myalgia
headach
fever
chill
fatigu
stool
examin
detect
oocyst
unc
chapel
hill
stool
specimen
concentr
use
formalinethyl
acet
concentr
procedur
routin
use
examin
ova
parasit
stool
specimen
addit
increas
sensit
detect
stool
first
week
postdos
concentr
sucros
floatat
procedur
aliquot
concentr
sampl
procedur
examin
microscop
use
wet
mount
prepar
concentr
confirm
second
laboratori
cdc
criteria
identifi
cyclospora
oocyst
base
size
morpholog
characterist
abil
oocyst
autofluoresc
epifluoresc
inoculum
treatment
challeng
condit
studi
describ
tabl
number
stool
examin
per
volunt
rang
oocyst
detect
stool
sampl
volunt
experienc
brief
episod
abdomin
cramp
day
postdos
volunt
attribut
symptom
possibl
dehydr
due
strenuou
activ
perform
heat
day
volunt
produc
four
loos
stool
day
postdos
report
feel
well
volunt
also
mildli
elev
leukocyt
count
x
normal
rang
x
day
postdos
howev
volunt
mildli
elev
baselin
leukocyt
count
x
day
dose
overal
conclus
evid
base
clinic
parasitolog
diagnost
procedur
show
volunt
becam
infect
cyclosporiasi
continu
difficult
emerg
infecti
diseas
understand
result
consist
research
inabl
establish
c
cayetanensi
infect
wide
varieti
anim
model
given
result
question
relat
host
suscept
risk
factor
infect
cyclospora
biolog
c
cayetanensi
surviv
condit
c
cayetanensi
vitro
vivo
factor
allow
cyclospora
becom
infecti
environ
need
studi
host
suscept
risk
factor
infect
alway
consider
evalu
host
respons
pathogen
exposur
epidemiolog
data
suggest
immun
may
develop
c
cayetanensi
area
cyclosporiasi
endem
diseas
sever
popul
person
affect
foodborn
outbreak
cyclosporiasi
north
america
mostli
adult
experienc
prolong
symptomat
gastroenter
median
foodspecif
attack
rate
high
studi
healthi
adult
volunt
year
age
recruit
area
cyclosporiasi
known
endem
therefor
although
number
volunt
studi
small
n
epidemiolog
data
suggest
host
suscept
factor
substanti
contribut
inabl
inocula
caus
infect
volunt
dose
administ
virul
characterist
cyclospora
necessari
infect
human
host
unknown
nucleotid
sequenc
variabl
first
intern
transcrib
spacer
region
within
c
cayetanensi
differ
geograph
origin
observ
suggest
exist
multipl
strain
addit
data
cryptosporidium
human
volunt
studi
demonstr
infecti
dose
differ
oocyst
depend
isol
use
studi
reason
attempt
vari
inocula
select
oocyst
person
differ
geograph
region
haiti
missouri
georgia
increas
number
oocyst
ingest
volunt
oocyst
approxim
cours
studi
thu
differ
virul
characterist
c
cayetanensi
isol
appear
major
factor
fail
establish
infect
oocyst
stool
sampl
studi
store
potassium
dichrom
final
inoculum
prepar
disinfect
bleach
cryptosporidium
parvum
store
potassium
dichrom
week
week
remain
infecti
human
volunt
cell
cultur
anim
also
baboon
inocul
oocyst
never
expos
potassium
dichrom
infect
cyclospora
eberhard
unpub
data
parasit
genera
relat
cyclospora
cryptosporidium
eimeria
spp
toxoplasma
gondii
sporocyst
sarcocysti
spp
shown
resist
high
level
bleach
howev
effect
potassium
dichrom
bleach
cyclospora
oocyst
use
studi
unknown
sinc
method
evalu
infect
viabil
avail
natur
occur
cyclospora
oocyst
may
surviv
extend
period
environ
given
mark
season
infect
area
diseas
endem
howev
mani
question
remain
trigger
condit
necessari
cyclospora
oocyst
surviv
becom
infecti
environ
given
result
studi
condit
necessari
cyclospora
becom
infecti
probabl
achiev
prepar
store
oocyst
futur
studi
necessari
examin
individu
combin
effect
temperatur
humid
storag
media
disinfect
surviv
viabil
infect
store
cyclospora
oocyst
studi
would
help
determin
optim
condit
stimul
sporul
maintain
infect
oocyst
vitro
time
howev
studi
possibl
suitabl
cell
cultur
system
anim
host
model
cyclosporiasi
develop
